Future Directions of Allergen Immunotherapy
Current Otorhinolaryngology Reports · 14.05.2026 · 14 (1)
DOI: 10.1007/s40136-026-00550-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Otorhinolaryngology Reports, online erschienen am 14.05.2026. Verfasst von Emily Stoller und 2 weiteren Autor:innen. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose of Review This review summarizes the current literature on Allergen Immunotherapy (AIT) for allergic rhinitis (AR), emphasizing recent innovations aimed at improving symptom control, safety, and adherence. Recent Findings AIT is a disease-modifying treatment for AR, with subcutaneous and sublingual immunotherapies serving as standards of care. Emerging approaches include alternative administration routes, immune modulation strategies, and modified allergen formulas. Intralymphatic immunotherapy has demonstrated efficacy comparable to established therapies while reducing injections, although long-term outcomes remain under investigation. Combination therapies using biologic agents such as dupilumab and adjuvant-based constructs including virus-like particles may improve symptom burden by shifting the immune response away from the type 2 inflammation pathway. Modified allergen formulas, such as allergoids, recombinant allergens, and peptide constructs, seek to reduce IgE-mediated allergenicity while maintaining immunogenicity. Summary Despite promising advances, high cost, variable response, and limited long-term safety data remain important challenges in AIT development.
Zitieren
APA
Stoller, E., Kong, K. A., & Franzese, C. (2026). Future Directions of Allergen Immunotherapy. Current Otorhinolaryngology Reports, 14(1). https://doi.org/10.1007/s40136-026-00550-2
Vancouver
Stoller E, Kong KA, Franzese C. Future Directions of Allergen Immunotherapy. Current Otorhinolaryngology Reports. 2026;14(1). doi:10.1007/s40136-026-00550-2
BibTeX
@article{Stoller2026,
author = {Stoller, Emily and Kong, Keonho A. and Franzese, Christine},
title = {Future Directions of Allergen Immunotherapy},
journal = {Current Otorhinolaryngology Reports},
year = {2026},
volume = {14},
number = {1},
doi = {10.1007/s40136-026-00550-2}
}
EUVIMED